Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products.

Marzo A, Balant LP.

Arzneimittelforschung. 1995 Feb;45(2):109-15. Review.

PMID:
7710428
[PubMed - indexed for MEDLINE]
2.

Variability and impact on design of bioequivalence studies.

Van Peer A.

Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):146-53. doi: 10.1111/j.1742-7843.2009.00485.x. Epub 2009 Nov 11. Review.

PMID:
20041877
[PubMed - indexed for MEDLINE]
3.

Open questions in bioequivalence.

Marzo A.

Pharmacol Res. 1995 Oct;32(4):237-40.

PMID:
8866840
[PubMed - indexed for MEDLINE]
4.

Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalence.

Tothfalusi L, Endrenyi L, Arieta AG.

Clin Pharmacokinet. 2009;48(11):725-43. doi: 10.2165/11318040-000000000-00000. Review.

PMID:
19817502
[PubMed - indexed for MEDLINE]
5.

Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and development of generic substitutes.

Adams WP, Poochikian G, Taylor AS, Patel RM, Burke GP, Williams RL.

J Aerosol Med. 1994;7(2):119-34. Review.

PMID:
10147277
[PubMed - indexed for MEDLINE]
6.

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, Yang Y, Yu LX, Woodcock J.

Ann Pharmacother. 2009 Oct;43(10):1583-97. doi: 10.1345/aph.1M141. Epub 2009 Sep 23.

PMID:
19776300
[PubMed - indexed for MEDLINE]
7.

The bioequivalence of highly variable drugs and drug products.

Midha KK, Rawson MJ, Hubbard JW.

Int J Clin Pharmacol Ther. 2005 Oct;43(10):485-98. Review.

PMID:
16240706
[PubMed - indexed for MEDLINE]
8.

International harmonization of bioequivalence studies and issues shared in common.

Nakai K, Fujita M, Ogata H.

Yakugaku Zasshi. 2000 Nov;120(11):1193-200.

PMID:
11190204
[PubMed - indexed for MEDLINE]
9.

Open questions on bioequivalence: an updated reappraisal.

Marzo A.

Curr Clin Pharmacol. 2007 May;2(2):179-89. Review.

PMID:
18690864
[PubMed - indexed for MEDLINE]
10.

Open questions on bioequivalence: some problems and some solutions.

Marzo A.

Pharmacol Res. 1999 Oct;40(4):357-68. Review.

PMID:
10527649
[PubMed - indexed for MEDLINE]
11.

Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.

Meredith PA.

Curr Med Res Opin. 2009 Sep;25(9):2179-89. doi: 10.1185/03007990903116867. Review.

PMID:
19601710
[PubMed - indexed for MEDLINE]
12.

Bioequivalence and other unresolved issues in generic drug substitution.

Meredith P.

Clin Ther. 2003 Nov;25(11):2875-90.

PMID:
14693311
[PubMed - indexed for MEDLINE]
13.

Veterinary drug bioequivalence determination.

Toutain PL, Koritz GD.

J Vet Pharmacol Ther. 1997 Apr;20(2):79-90. Review.

PMID:
9131533
[PubMed - indexed for MEDLINE]
14.

Challenges associated with the evaluation of veterinary product bioequivalence: an AAVPT perspective.

Martinez M, Langston C, Martin T, Conner D.

J Vet Pharmacol Ther. 2002 Jun;25(3):201-20.

PMID:
12081616
[PubMed - indexed for MEDLINE]
15.

[Bioequivalence studies of pharmaceutical preparations].

Vetchý D, Frýbortová K, Rabisková M, Danecková H.

Cas Lek Cesk. 2007;146(5):431-3. Review. Czech.

PMID:
17554963
[PubMed - indexed for MEDLINE]
16.

Quantitative assessment of the switchability of generic products.

Karalis V, Bialer M, Macheras P.

Eur J Pharm Sci. 2013 Nov 20;50(3-4):476-83. doi: 10.1016/j.ejps.2013.08.023. Epub 2013 Aug 24.

PMID:
23981332
[PubMed - indexed for MEDLINE]
17.

Bioequivalence of racemic drugs.

Nerurkar SG, Dighe SV, Williams RL.

J Clin Pharmacol. 1992 Oct;32(10):935-43. Review.

PMID:
1447402
[PubMed - indexed for MEDLINE]
18.

Bioequivalence requirements for generic products.

Nation RL, Sansom LN.

Pharmacol Ther. 1994 Apr-May;62(1-2):41-55. Review.

PMID:
7991647
[PubMed - indexed for MEDLINE]
19.

Bioequivalence assessment: a pharmaceutical industry perspective.

Godbillon J, Cardot JM, Lecaillon JB, Lefevre G, Sioufi A.

Eur J Drug Metab Pharmacokinet. 1996 Apr-Jun;21(2):153-8. Review.

PMID:
8839689
[PubMed - indexed for MEDLINE]
20.

The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.

Borgheini G.

Clin Ther. 2003 Jun;25(6):1578-92. Review.

PMID:
12860486
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk